Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 18, 2025
Outset Medical Announces One-for-Fifteen Reverse Stock Split
GlobeNewswire
·
March 18, 2025
SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced a one- …
AI in Remote Patient Monitoring Market worth US$8,438.5 million by 2030 with 27.5% CAGR | MarketsandMarkets™.
GlobeNewswire
·
March 18, 2025
Delray Beach, FL, March 18, 2025 (GLOBE NEWSWIRE) -- The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust CAGR of 27.5%, reaching US$1967.7 million in 2024 and an impressive US$8438.5 …
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025
GlobeNewswire
·
March 18, 2025
WAYNE, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare …
March 2025 Letter to Shareholders
GlobeNewswire
·
March 18, 2025
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. (“CytoDyn” or the “Company”). On February 24, 2025, the Company announced increased survival rates in …
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
GlobeNewswire
·
March 18, 2025
BERKELEY HEIGHTS, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will …
New InStride Health Data Reveals Overall Clinical Improvement in 98% of Youth with Anxiety and/or OCD
GlobeNewswire
·
March 18, 2025
BOSTON, March 18, 2025 (GLOBE NEWSWIRE) -- InStride Health, an outpatient provider of specialty pediatric anxiety and Obsessive-Compulsive Disorder (OCD) treatment, today announced new data reflecting clinically meaningful results of its program’s impact …
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
GlobeNewswire
·
March 18, 2025
HANOVER, Md., March 18, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
GlobeNewswire
·
March 18, 2025
Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) -- IM8, the premium supplements brand co-founded by David Beckham, …
Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
GlobeNewswire
·
March 18, 2025
Ramat Gan, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection
GlobeNewswire
·
March 18, 2025
VANCOUVER, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports the following news release was issued by Omega Laboratories, Inc. today. MOGADORE, …
Cytrellis Secures Health Canada and Saudi Food and Drug Authority Approval for ellacor® with Micro-Coring® Technology
GlobeNewswire
·
March 18, 2025
WOBURN, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems, a medical technology company specializing in novel aesthetic solutions, today announces that it has received approval from Health Canada and the Saudi Food and Drug Authority (SFDA) to …
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
GlobeNewswire
·
March 18, 2025
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that the Company will participate in …
SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024.
GlobeNewswire
·
March 18, 2025
TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- – SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through …
New Report Highlights 100+ Actionable Strategies for Climate-Resilient Water and Sanitation in Frontline Communities Across US
GlobeNewswire
·
March 18, 2025
Oakland, CA, USA, March 18, 2025 (GLOBE NEWSWIRE) -- New research released today by the Pacific Institute and DigDeep outlines over 100 actionable strategies for frontline communities’ water and sanitation systems in the face of intensifying climate …
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
GlobeNewswire
·
March 18, 2025
OCU200 has a very favorable safety and tolerability profile No serious adverse events related to the study drug have been reported Dosing of the second cohort has been approved MALVERN, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the …
Ashvattha Therapeutics Accelerates Clinical Development Strategy with Leadership Appointment of Six Leading Retinal Specialists to Clinical Advisory Board
GlobeNewswire
·
March 18, 2025
REDWOOD CITY, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …
Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board
GlobeNewswire
·
March 18, 2025
NEEDHAM, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States
GlobeNewswire
·
March 18, 2025
Medis will have exclusive distribution rights in 17 EU and non-EU countries for givinostat once approved Regulatory approvals for givinostat as a treatment of Duchenne muscular dystrophy obtained in the US and UK; EMA evaluation ongoing MILAN and LJUBLJANA …
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
GlobeNewswire
·
March 18, 2025
With decades of experience in pharmaceutical development and extensive genetic medicine expertise, Doug E. Williams, Ph.D., and Murray Stewart, DM FRCP, will provide strategic guidance for CAMP4’s multiple drug development efforts CAMBRIDGE, Mass., March …
Sutter Health and Alignment Healthcare Renew Long-Term, Strategic Collaboration
GlobeNewswire
·
March 18, 2025
Agreement brings continued access to high-quality care for Alignment’s Medicare Advantage members ORANGE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Sutter Health and Alignment Healthcare, Inc. (NASDAQ: ALHC) have renewed their agreement that provides …